References
- Shriver D A, Rosenthale M E, Kluender H C, Schut R N, McGuire J L, Hong E. Pharmacology of rio-prostil, a new gastric cytoprotective/antisecretory agent. Arzneim Forsch/Drug Res 1985; 35(I)839–843
- Demol P, Wingender W, Weihrauch T R, Graefe K H. Inhibition of gastric secretion in man by rio-prostil, a new synthetic methyl prostaglandin E. Arzneim Forsch/Drug Res 1985; 35(I)861–863
- Demol P, Schmitz H D, Weihrauch T R, Kuhlmann J. Prevention of the acetylsalicylic acid-induced changes of the gastric potential difference by the new synthetic prostaglandin E1 analogue rioprostil. Arzneim Forsch/Drug Res 1986; 36(II)1406–1408
- Sanders K M. Role of prostaglandin in regulating gastric motility. Am J Physiol 1984; 247: G117–G126
- Demol P, Wingender W, Weihrauch T R, Kuhlmann J. 6th Int Conference on Prostaglandins and related compounds. 1986, 213, Florence(Abstract)
- Manninen V, Melin J, Apajalathi A, Karesoja M. Altered absorption of digoxin in patients given propantheline and metoclopromide. Lancet 1973; i: 398–399
- Kuhlmann J, Zilly W, Wilke J. Effects of cytostatic drugs on plasma level and renal excretion of β-acetyldigoxin. Clin Pharmacol Ther 1981; 30: 518–527
- Dammann H G, Walter T A, Muller P, Simon B. Rioprostil 600 u.g nocte: high duodenal ulcer healing rates, low incidence of side effects. Gastroenterology 1986; 90: 1386, 5(2)
- Hinder R A, Kelly K A. Canine gastric emptying of solids and liquids. Am J Physiol 1977; 233: E335–E340
- Nimmo J, Heading R C, Tothill P, Prescott L F. Pharmacological modification of gastric emptying: effects of propantheline and metoclopromide on paracetamol absorption. Br Med J 1973; 1: 587–591